Company Overview

Business Description

Headquarters
Canada CA
IPO date
May 18, 2012

Voyageur Pharmaceuticals Ltd is a Canadian specialty pharmaceutical company focused on diagnostic imaging products. It works on contrast agents, especially barium-based products used to help doctors see the gastrointestinal tract in X-ray and CT imaging. The company also develops related formulations and mineral-based pharmaceutical ingredients that sit upstream in the medical imaging supply chain.

Its customers are hospitals, imaging centers, and pharmaceutical partners that need contrast media for diagnostic procedures. Voyageur makes money by selling these products and, where applicable, by licensing or commercializing its formulations and related technology. In simple terms, it is trying to turn naturally sourced raw materials into medical imaging products that can be used in routine scans.

What makes the business different is that it is not a broad drug maker. It is concentrated on a narrow set of imaging materials and on controlling the formulation and supply of those materials. That gives it a specialized role in the healthcare chain: supplying the substances that make certain scans readable and useful to doctors.

Voyageur Pharmaceuticals Ltd Investor Relations

Address
Dome Tower 800, 333 7 Ave. S.W.
Calgary, Alberta
Canada

Business Segments

Contrast media

Voyageur Pharmaceuticals develops and works to sell medical imaging contrast products, mainly barium-based materials used to help doctors see the digestive system in X-rays and related scans.

Customers and revenue model

Management

Mr. Brent Willis Bsc.Eng

President, CEO & Director

Biography unavailable

Mr. Bradley Craig Willis P.Eng.

Founder, COO & Director

Biography unavailable

Mr. Albert Deslauriers

Chief Financial Officer

Biography unavailable

Mr. Ethan Mohan

Sales Manager

Biography unavailable

1 / 4